LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
02/18/2025
Back to search
Official data from USPTO
SIRTEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
49
Latest update
02/18/2025
Trademark type
Word
Nice classes
5, 42
Filing date
10/24/2011
Registration date
12/04/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/15/2022
Last transaction
02/18/2025
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
NORTH SYDNEY, AU
Examiner
MACFARLANE, JAMES
Law office
L40
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Sirtex Medical Limited
Sirtex Medical Limited
Representatives
Gwenn Roos OnsideCounsel/Law Office of Gwenn Roos
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of cancer; biological preparations for medical and veterinary purposesfor the treatment of cancer; capsules and particles in the nature of radio-isotopesradionuclideschemotherapeutic agents and magnetic materials for medical and pharmaceutical purposes for the treatment of cancer; chemical preparations for medical and pharmaceutical purposes for the treatment of cancer; chemical preparations for veterinary purposes for the treatment of cancer; drugs for medical purposes for the treatment of cancer; microcapsules for the treatment of cancer; microscopic particles in the nature of radio-isotopesradionuclideschemotherapeutic agents and magnetic materials containing radioactive material for medical therapeutic use for the treatment of cancer; microcapsules containing pharmaceuticalveterinary or medical preparations for the treatment of cancer; microcapsules and microparticles in the nature of radio-isotopesradionuclideschemotherapeutic agents and magnetic materials adapted to selectively deliver materialincluding radioactive materialschemical agents and heatto a target site such as a cell or organ for the treatment of cancer; microscopic particles in the nature of radio-isotopesradionuclideschemotherapeutic agents and magnetic materials and microcapsules for the treatment of cancer; microscopic particles in the nature of radio-isotopesradionuclideschemotherapeutic agents and magnetic materials adapted to selectively deliver materialincluding radioactive materialschemical agents and heatto a target site such as a cell or organ for the treatment of cancer
Class 42
Medical research; scientific research for medical purposes; research and development of medical and veterinary products for medical and veterinary purposesincluding pharmaceuticalsmicrocapsulesmicroparticlesradioactive materialschemical agents and preparationscancer treatments and treatments for diseased cells; medical and scientific research relating to molecular sciencespharmaceuticalsdrugschemicals and biotechnology
Publications
History of USPTO decisions and trademark events.
49 publications found
RHRD
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
08/31/2024
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
06/15/2022
71AG
REGISTERED-SEC.71 ACCEPTED
06/15/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/31/2022
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
05/09/2022
RHRD
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
04/02/2022
ES71
TEAS SECTION 71 RECEIVED
12/05/2021
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
12/04/2021
RNWL
INTERNATIONAL REGISTRATION RENEWED
11/11/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/09/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/27/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/27/2019
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
01/30/2019
RHRD
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
01/24/2019
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
04/24/2018
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
04/24/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/24/2018
ES75
TEAS SECTION 71 & 15 RECEIVED
04/03/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/25/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/06/2013
FIMP
FINAL DISPOSITION PROCESSED
03/06/2013
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/04/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
12/04/2012
GPNX
NOTIFICATION PROCESSED BY IB
10/16/2012
PUBO
PUBLISHED FOR OPPOSITION
09/18/2012
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/29/2012
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/29/2012
NPUB
NOTICE OF PUBLICATION
08/29/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/14/2012
CNEA
EXAMINERS AMENDMENT MAILED
08/13/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/13/2012
XAEC
EXAMINER'S AMENDMENT ENTERED
08/13/2012
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/13/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/02/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/02/2012
ALIE
ASSIGNED TO LIE
07/20/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/18/2012
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/17/2012
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/17/2012
RFNT
REFUSAL PROCESSED BY IB
03/24/2012
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/01/2012
RFRR
REFUSAL PROCESSED BY MPU
03/01/2012
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/29/2012
CNRT
NON-FINAL ACTION WRITTEN
02/28/2012
MAFR
APPLICATION FILING RECEIPT MAILED
02/28/2012
DOCK
ASSIGNED TO EXAMINER
02/24/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/24/2012
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/23/2012
Continuous trademark protection
Get notified about every new filing that threatens SIRTEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.